Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


Home > Past Briefings
 

Past Briefings

Change Text Size:   Smaller Text Size   Larger Text Size   Default Text Size    

The following is a list of all previous briefings for the year 2016. For briefings from other years, select from the list below.

Post-Election Symposium: Health Care Policy in 2017
Wednesday, November 16, 2016

This post-election, half-day symposium previewed critical 2017 health care policy issues. Our panelists reviewed what we can learn from the election results and public opinion, what priorities we can expect for the new Trump administration, and what health care issues will be on the agenda for the new Congress.

Medicare and Prescription Drug Prices
Wednesday, October 26, 2016

While recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, and preventing disease, stakeholders throughout the health care system have serious concerns about prescription drug affordability. Payment methods that incorporate concepts of value and patient-centered care are among the emerging policy options to address the cost of drugs for Medicare patients. This briefing featured presentations by our experts highlighting the trends in Medicare regarding prescription drug pricing, and panelists discussed an array of policy options to align drug prices with value through alternative payment models.

Health Care for Veterans: Where Things Stand & Next Steps
Friday, October 21, 2016

The enactment of the Veterans Choice Act in 2014 renewed discussions about the capacity of the VA health care system to meet the needs of our nation's veterans. In addition to tackling issues related to access to VA-owned facilities, the Veterans Choice Act prompted a thorough examination of the quality of care provided to veterans in the VA system, the VA's ability to purchase care from the private sector, and the VA's capacity to provide services. This briefing provided an introduction to the VA health system, presented an overview of how the VA acts as both provider and purchaser of care, and discussed policy prospects for the future.

Open Enrollment Preview: Checking the Vitals of the Marketplaces
Monday, September 26, 2016

The Affordable Care Act's health insurance marketplaces rely on robust competition to control costs and to provide consumer choice. But the decisions of several large insurers to scale back their 2017 marketplace participation, and the failure of many health insurance co-ops will leave marketplace shoppers in many states with fewer choices than they had in 2016. Furthermore, those insurers remaining in the exchanges have often found their marketplace customers to be less healthy than they projected, and they are raising premiums in response. Our briefing focuses on these trends, what they mean for the long-term viability of the marketplaces, and what public policy steps can be taken to bring more healthy people into the risk pool and to encourage insurer participation in the individual market.

Assessing Innovations in Medicaid
Friday, September 23, 2016

Medicaid is testing numerous new alternative payment and delivery system models to enhance the coordination of the health care services provided to millions of low-income Americans. This briefing examined the range of Medicaid’s efforts to improve care and promote value, including integrating health with non-clinical and behavioral services, creating managed care organizations, and instituting regional care collaborative organizations.

High-Need, High-Cost Patients: Challenges & Promising Models
Monday, August 29, 2016

Health systems have applied many innovative new strategies for improving quality and reducing costs when it comes to care for high-need, high-cost patients, who typically have multiple chronic conditions. Which of these innovations show promise, and what can we learn from them? This briefing defines who high-need, high-cost patients are, discusses the importance of this population to health system transformation, presents current data on this population, and emphasizes the core elements of successful interventions.

Zika Virus: Control, Monitoring, and Prevention
Thursday, August 11, 2016

At our briefing for reporters at the National Press Club, NIH's Anthony Fauci provided an update on the state-of-play of the Zika virus in the U.S. A panel representing federal, state and local officials then discussed details of how the response will be coordinated and where resources are needed.

Trends in Coverage and Affordability on the ACA Marketplaces
Friday, July 15, 2016

In advance of the fourth open enrollment period for health coverage under the Affordable Care Act (ACA), which begins Nov. 1, this briefing examined who has gained coverage, who remains uninsured, and why uninsured individuals have not obtained coverage. Speakers also discussed marketplace stability, factors driving premium trends, and the outlook for 2017 premiums.

MACRA: Stakeholder Considerations and Next Steps
Monday, July 11, 2016

The implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) could have broad implications for physicians, health systems, health plans, consumers and others. This briefing explored the key concerns and considerations raised during the comment period, along with possibilities and prospects for moving forward.

Briefing for Reporters on MACRA & Medicare Payments
Thursday, June 30, 2016

This briefing reviews the requirements of MACRA, including MIPS, the APMs and the choices physicians will need to make. We also examined what this means for doctor practices and health systems who employ doctors, including what the burden of quality reporting will be for these groups, what the relative impact will be for large and small practices, and how this might accelerate or slow the trend toward provider consolidation.

Biosimilars in the United States: Next Steps
Monday, June 20, 2016

With biosimilar biological products moving from the lab to the marketplace, key policy and regulatory questions are being actively debated, with important implications for industry, patients, and the health care system. This discussion will provide background on current policy and regulatory issues surrounding biosimilars, and it will consider implications for the future, answering critical questions such as: What does the future of the biosimilars market hold for patients? What information do patients and their physicians need about these medicines? What role will payers play in educating health care professionals and patients?

MACRA: New Directions for Medicare Physician Payment
Friday, May 20, 2016

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) repealed the Sustainable Growth Rate formula (SGR) and set out a blueprint for reforming physician payment under Medicare with an eye towards better aligning Medicare payments with the cost and quality of patient care. On April 27, 2016, the Department of Health and Human Services (HHS) issued a proposed rule to implement the law. While the proposed rule provides more clarity on how to move the health care system from volume to value, questions about implementing the law remain among policymakers, providers, and patients.

Value-Based Pricing for Prescription Drugs: Opportunities and Challenges
Friday, April 15, 2016

Recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, or preventing a range of diseases. However, patients, providers and payers alike have raised concerns about the affordability and sustainability of these drugs. As a response to price increases of both single-source and generic drugs, some stakeholders are calling for a move towards basing payments on value, and some payers and pharmaceutical manufacturers are exploring ways to base payments on outcomes. However, many challenges remain.

Medicare Payment System Reforms: What Do We Know?
Monday, April 11, 2016

Medicare is testing new ways to pay for medical services, emphasizing value rather than volume, and evidence is beginning to build about successes and challenges. This briefing will examine what we know so far about the basic models, savings, quality, the impact on patients and the prospects for replication.

Alliance for Health Reform Names Co-CEOs
Thursday, March 24, 2016

Washington veterans Sarah Dash and Marilyn Serafini promoted from VP positions to co-lead The Alliance for Health Reform

Briefing for Reporters on State Health Initiatives
Friday, February 19, 2016

A governor met with reporters Friday, February 19 to discuss the latest health care innovations and changes they are pursuing or implementing. Gov. Asa Hutchinson, R-Ark., discussed his experience with the state's program to move newly eligible Medicaid beneficiaries to qualified health plans, and his intentions for changes moving forward.

 


Webcast: The Emerging Biosimilars Market


Watch the webcast of our June 20 panel discussion on biosimilar biological medications.

Read More 

Open Enrollment Preview: Checking the Vitals of the Marketplaces


The Affordable Care Act's health insurance marketplaces rely on robust competition to control costs and to provide consumer choice. But the decisions of several large insurers to scale back their 2017 marketplace participation, and the failure of many health insurance co-ops will leave marketplace shoppers in many states with fewer choices than they had in 2016. Furthermore, those insurers remaining in the exchanges have often found their marketplace customers to be less healthy than they projected, and they are raising premiums in response. Our briefing focuses on these trends, what they mean for the long-term viability of the marketplaces, and what public policy steps can be taken to bring more healthy people into the risk pool and to encourage insurer participation in the individual market.

Read More

Copyright 1997-2016 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      info@allhealth.org      Sitemap